Genzyme Belgium Genzyme Corporate Search Contact us
HealthcarePatients & FamiliesPractical Info
A disease with many faces
 
Healthcare Professionals
About Lysosomal Storage Disease
Gaucher
Fabry
MPS I
Pompe
Disease Information
Management of Pompe Disease
Medical Information Services
Pompe Registry
Practical Info
Request Materials
Testimonials on the Pompe disease

 



 

Practical Information

Summary of Product Characteristics Myozyme®

Click here for Dutch version (PDF)

Click here for French version (PDF)

RIZIV/INAMI reimbursement criteria for Myozyme®

Click here for Dutch version of Myozyme® reimbursement criteria (PDF).

Click here for French version of Myozyme® reimbursement criteria (PDF).

Click here for Dutch version of the parameters for Myozyme® reimbursement prolongation (.xls)

Click here for French version of the parameters for Myozyme® reimbursement prolongation (.xls)

Reconstitution and Administration of Myozyme®

To access information about the steps required to reconstitute and administer Myozyme, Download below:

Reconstitution & Administration (PDF)

Medical Services

Click here to access Genzyme’s Medical Information Services

Click here to access the list of laboratories in Belgium that are known to perform testing for lysosomal storage disorders.

Click here to access the list of metabolic reference centers in Belgium.

Click here to access the list of neuromuscular reference centers in Belgium.

Click here to access the list of the Centers for Human Genetics in Belgium.

 
Print

PRINT

Bookmark

BOOKMARK




01/01/2007: Low bone density in Gaucher disease improves with Cerezyme®

01/05/2007: Treatment for Pompe disease now available for Belgian patients

01/03/2006: Early treatment with Fabrazyme® significantly slows progression of Fabry

More >



Lysosomal Storage Disorders
General information
Gaucher Disease
Fabry Disease
MPS I Disease
Pompe Disease